News & Press

Fabric Genomics and TOMA Biosciences announced a partnership in April to develop an end-to-end genomic testing and clinical interpretation product for somatic cancers. The new system integrates TOMA’s oligo selective sequencing (OS-Seq) technology, which was developed at Stanford University, and combines it with Fabric Genomics’ bioinformatics platform. “What TOMA does is a very specialized assay …

Read More